aTYR PHARMA INC (ATYR) Operating cash flow 2016–2025
aTYR PHARMA INC (ATYR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.0MFY2025 · since FY2016: -$52.9M → -$62.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.0M | +10.3% |
| FY2024 | -$69.1M | -108.1% |
| FY2023 | -$33.2M | +20.7% |
| FY2022 | -$41.9M | -26.6% |
| FY2021 | -$33.1M | -116.2% |
| FY2020 | -$15.3M | +23.5% |
| FY2019 | -$20.0M | +35.6% |
| FY2018 | -$31.1M | +26.7% |
| FY2017 | -$42.4M | +19.9% |
| FY2016 | -$52.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Net marginATYR Gross profitATYR Gross marginATYR Operating incomeATYR Operating marginATYR Free cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Total liabilitiesATYR Shareholders’ equityATYR overview →